Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Sunday, October 1, 2006

The diagnosis of a hereditary clotting disorder can provoke anxiety in many patients, especially those who require lifelong therapy with warfarin. A number of resources are available to educate these patients about their disorder and the management of it.

A wealth of information is available for patients to access on the Internet. Some reliable Web sites include:

? comprehensive site for health care providers, patients, and caregivers; frequent updates on recent studies as well as educational materials on a variety of management issues

? information, patient education, helpful links to information about warfarin treatment

? educational materials for patients and caregivers that explain deep vein thrombosis, unstable angina, the clotting mechanism, and the cardiovascular system

? to patients living with Factor V Leiden disorder and other types of thrombophilia

? National Alliance for Thrombosis and Thrombophilia (NATT), a grassroots advocacy network. Newsletters, patient stories, research news, and general information dedicated to patients with thrombosis or thrombophilia are included.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues